3 December 2023
- 23:1823:18, 3 December 2023 diff hist +68 Training: Oncological Expertise (Eugène Marquis Cancer Centre) No edit summary
- 23:1623:16, 3 December 2023 diff hist +68 Experts (Eugène Marquis Cancer Centre) No edit summary
- 23:1523:15, 3 December 2023 diff hist +25 Eugène Marquis Cancer Centre →Trials (Eugène Marquis Cancer Centre)
- 23:1523:15, 3 December 2023 diff hist +91,129 N Trials (Eugène Marquis Cancer Centre) Created page with "{{forpatients}} {{forproviders}} {{forresearchers}} Go back to Eugène Marquis Cancer Centre page '''NCTID''': NCT02444000 '''Title''': gliomasPCV Only in 1p/19q Codeleted Anaplastic Gliomas '''Study Summary''': Patients with 1p/19q-codeleted anaplastic gliomas treated with RT + PCV are at risk of neurocognitive deterioration. Treating these patients with PCV alone (could reduce the risk of neurocognitive deterioration without impairing overall survival. '''Sp..."
- 23:1423:14, 3 December 2023 diff hist −88 Eugène Marquis Cancer Centre →Trials
- 23:1123:11, 3 December 2023 diff hist +113 Service: Supportive Care (Institut de Cancérologie de lOuest (ICO) - Integrated Center for Oncology) No edit summary
- 23:1123:11, 3 December 2023 diff hist +113 Resource: Trials List (Institut de Cancérologie de lOuest (ICO) - Integrated Center for Oncology) No edit summary
- 23:1023:10, 3 December 2023 diff hist +113 Patient Association: Associations List (Institut de Cancérologie de lOuest (ICO) - Integrated Center for Oncology) No edit summary
- 23:1023:10, 3 December 2023 diff hist +113 Novel Therapies and Diagnostic Methods (Institut de Cancérologie de lOuest (ICO) - Integrated Center for Oncology) No edit summary
- 23:0923:09, 3 December 2023 diff hist +114 Training: List for Physiotherapists (Institut de Cancérologie de lOuest (ICO) - Integrated Center for Oncology No edit summary
- 23:0923:09, 3 December 2023 diff hist +114 Training: List for Health Professionals (Institut de Cancérologie de lOuest (ICO) - Integrated Center for Oncology) No edit summary
- 23:0823:08, 3 December 2023 diff hist +1 Experts (Institut de Cancérologie de lOuest (ICO) - Integrated Center for Oncology) No edit summary
- 23:0823:08, 3 December 2023 diff hist +113 Experts (Institut de Cancérologie de lOuest (ICO) - Integrated Center for Oncology) No edit summary
- 23:0423:04, 3 December 2023 diff hist +24 Institut de Cancérologie de l'Ouest (ICO) - Integrated Center for Oncology →Trials (Institut de Cancérologie de l'Ouest (ICO) - Integrated Center for Oncology)
- 23:0323:03, 3 December 2023 diff hist +259,656 N Trials (Institut de Cancérologie de l'Ouest (ICO) - Integrated Center for Oncology) Created page with "{{forpatients}} {{forproviders}} {{forresearchers}} Go back to Institut de Cancérologie de l'Ouest (ICO) - Integrated Center for Oncology page '''NCTID''': NCT03943667 '''Title''': Gemcitabine and Paclitaxel vs Gemcitabine Alone After FOLFIRINOX Failure in Metastatic Pancreatic Ductal Adenocarcinoma '''Study Summary''': This study aims to evaluate whether the combination of gemcitabine and paclitaxel allows to improve the overall survival compared to gemcitabin..."
- 23:0223:02, 3 December 2023 diff hist −88 Institut de Cancérologie de l'Ouest (ICO) - Integrated Center for Oncology →Trials
- 23:0123:01, 3 December 2023 diff hist +112 Service: Hospital education (Armand-Trousseau Hospital) (APHP - Sorbonne Université - Institut Universitaire de Cancérologie(IUC)) No edit summary
- 23:0023:00, 3 December 2023 diff hist +112 Service: Health, Art and Culture Project at the Hospital (Rothschild Hospital) (APHP - Sorbonne Université - Institut Universitaire de Cancérologie(IUC)) No edit summary
- 23:0023:00, 3 December 2023 diff hist +112 Service: Educational and cultural activities (Roche-Guyon Hospital) (APHP - Sorbonne Université - Institut Universitaire de Cancérologie(IUC)) No edit summary
- 23:0023:00, 3 December 2023 diff hist +112 Resource: Trials List (APHP - Sorbonne Université - Institut Universitaire de Cancérologie(IUC)) No edit summary
- 23:0023:00, 3 December 2023 diff hist +112 Resource: Multi-Faith Oratory (Armand-Trousseau Hospital) (APHP - Sorbonne Université - Institut Universitaire de Cancérologie(IUC)) No edit summary
- 23:0023:00, 3 December 2023 diff hist +112 Patient Association: List of the Pediatric Hematology Oncology Service (Armand-Trousseau Hospital) (APHP - Sorbonne Université - Institut Universitaire de Cancérologie(IUC)) No edit summary
- 22:5922:59, 3 December 2023 diff hist +112 Novel Therapies and Diagnostic Methods (APHP - Sorbonne Université - Institut Universitaire de Cancérologie(IUC)) No edit summary
- 22:5822:58, 3 December 2023 diff hist +113 Trainings: List of Oncological Trainings (APHP - Sorbonne Université - Institut Universitaire de Cancérologie(IUC)) No edit summary
- 22:5822:58, 3 December 2023 diff hist +113 Experts (APHP - Sorbonne Université - Institut Universitaire de Cancérologie(IUC)) No edit summary
- 22:5722:57, 3 December 2023 diff hist +25 APHP - Sorbonne Université - Institut Universitaire de Cancérologie(IUC) →Trials (APHP - Sorbonne Université - Institut Universitaire de Cancérologie(IUC))
- 22:5722:57, 3 December 2023 diff hist +4,226 N Trials (APHP - Sorbonne Université - Institut Universitaire de Cancérologie(IUC)) Created page with "{{forpatients}} {{forproviders}} {{forresearchers}} Go back to APHP - Sorbonne Université - Institut Universitaire de Cancérologie(IUC) page '''NCTID''': NCT04622319 '''Title''': A Study of Trastuzumab Deruxtecan (T-DXd) Versus Trastuzumab Emtansine (T-DM1) in High-risk HER2-positive Participants With Residual Invasive Breast Cancer Following Neoadjuvant Therapy (DESTINY-Breast05) '''Study Summary''': Patients with HER2-positive primary breast cancer (BC) who..."
- 22:5622:56, 3 December 2023 diff hist −88 APHP - Sorbonne Université - Institut Universitaire de Cancérologie(IUC) →Trials
- 22:5422:54, 3 December 2023 diff hist +59 Service: List of Supportive Oncological Care (APHP-CARPEM Institute) No edit summary
- 22:5422:54, 3 December 2023 diff hist +59 Service: Religious Cults in the Hospital (APHP-CARPEM Institute) No edit summary
- 22:5422:54, 3 December 2023 diff hist +59 Resource: Trials List (APHP-CARPEM Institute) No edit summary
- 22:5222:52, 3 December 2023 diff hist +59 Novel Therapies and Diagnostic Methods (APHP-CARPEM Institute) No edit summary
- 22:5022:50, 3 December 2023 diff hist +60 Resource: Trainings List (APHP-CARPEM Institute) No edit summary
- 22:4922:49, 3 December 2023 diff hist +60 Experts (APHP-CARPEM Institute) No edit summary
1 December 2023
- 22:2322:23, 1 December 2023 diff hist +63 Service: Sophrology (Centre François Baclesse) No edit summary
- 22:2222:22, 1 December 2023 diff hist +63 Service: Plantar Reflexology (Centre François Baclesse) No edit summary
- 22:2222:22, 1 December 2023 diff hist +63 Service: Onco-sexuality (Centre François Baclesse) No edit summary
- 22:2222:22, 1 December 2023 diff hist +63 Service: Aesthetic Care and Image Consulting (Centre François Baclesse) No edit summary
- 22:2222:22, 1 December 2023 diff hist +63 Resource: Trials List (Centre François Baclesse) No edit summary
- 22:2122:21, 1 December 2023 diff hist +63 Novel Therapies and Diagnostic Methods (Centre François Baclesse) No edit summary
- 22:2122:21, 1 December 2023 diff hist +83 Resource: Training Catalog (Centre François Baclesse) No edit summary
- 22:1822:18, 1 December 2023 diff hist +64 Experts (Centre François Baclesse) No edit summary
- 22:1822:18, 1 December 2023 diff hist +25 Centre François Baclesse →Trials (Centre François Baclesse)
- 22:1722:17, 1 December 2023 diff hist +99 Trials (Centre François Baclesse) No edit summary
- 22:1622:16, 1 December 2023 diff hist +110,967 N Trials (Centre François Baclesse) Created page with "'''NCTID''': NCT01827943 '''Title''': Phase II Evaluating Efficacy of Temsirolimus in 2 Line Therapy for Patients With Advanced Bladder Cancer '''Study Summary''': In the absence of standard treatment in this indication, this test evaluates a new drug type targeted therapy in this indication, evaluating its efficacy in terms of tumor response and survival. '''Sponsor''': Institut Bergonié '''Intervention''': Temsirolimus '''Start Date''': 2009-06 '''Last Updated''..."
- 22:1622:16, 1 December 2023 diff hist −88 Centre François Baclesse →Trials
- 22:1422:14, 1 December 2023 diff hist +83 Resource: Wellbeing, Beauty and Self-image (University Cancer Institute Toulouse-Oncopole) No edit summary
- 22:1422:14, 1 December 2023 diff hist +83 Novel Therapies and Diagnostic Methods (University Cancer Institute Toulouse-Oncopole) No edit summary
- 22:1422:14, 1 December 2023 diff hist +103 Training Platform (University Cancer Institute Toulouse-Oncopole) No edit summary
- 22:1122:11, 1 December 2023 diff hist +84 Experts (University Cancer Institute Toulouse-Oncopole) No edit summary
